Biopharmaceutics & Drug Disposition
1998-09-01
Blood partition and protein binding of a new reversible proton pump inhibitor, YH1885.
K S Han, Y G Kim, J W Lee, M G Lee
Index: Biopharm. Drug Dispos. 19(6) , 413-5, (1998)
Full Text: HTML
Abstract
Related Articles:
In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
1992-04-01
[Mycopathologia 118(1) , 15-21, (1992)]
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
2009-05-01
[Antimicrob. Agents Chemother. 53 , 2181-4, (2009)]
Single dose therapy of vaginal candidiasis: a comparative trial of fenticonazole vaginal ovules versus clotrimazole vaginal tablets.
1990-01-01
[Curr. Med. Res. Opin. 12(2) , 114-20, (1990)]
Chiral discrimination by HPLC and CE and antifungal activity of racemic fenticonazole and its enantiomers.
2002-05-15
[Chirality 14(5) , 449-54, (2002)]
The development and validation of a high performance liquid chromatography (HPLC)/tandem mass spectrometry assay for fenticonazole in human plasma and comparison with an HPLC-UV method.
1995-01-01
[Rapid Commun. Mass Spectrom. 9(14) , 1452-6, (1995)]